Start Date
February 29, 2016
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
peginterferon beta-1a
SC administration as prescribed by the physician- initial dose of 63 μg followed by 94 μg dose on day 15 and 125 μg on day 29
brimonidine tartrate
Applied to injection site as specified in the treatment arm. Commercially available Mirvaso (Brimonidine tartrate) gel will be provided by Galderma.
Vehicle Gel
Matched placebo applied to injection site as specified in the treatment arm. Matching vehicle gel will be provided by Galderma.
Lead Sponsor
Biogen
INDUSTRY